[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_654 

# __Limited availability and effectiveness of antiviral treatments__

## Category to which it belongs

* [The propagation and transmission risks of respiratory viruses, including the coronavirus, and the need for standardized representation and understanding of virus spread, survival, and inactivation in various environments.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_133.md)

## Closest similar item

* [Limited efficacy against specific viruses](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1500.md)
* [Lack of drug therapies for covid-19](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_935.md)
* [Limited availability of medication and vaccines for covid-19](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_54.md)
* [Inactivation of virus](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3387.md)
* [Lack of medication and vaccines for covid-19](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1483.md)
* [Incomplete covid-19 prevention and mitigation information](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_836.md)
* [Effects of nebulization and impingement on viral survival](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2275.md)
* [Slow the spread of the coronavirus pandemic](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3390.md)
* [Inactivation of coronaviruses by biocidal agents in carrier tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1538.md)
* [Infection prevention](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2461.md)

## Mitigations of this risk

* [Development of graphene-based antiviral coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_918.md)

